• Most Popular
  • Most Shared

UK's NICE upholds block on Lilly lung cancer drug

Wed Aug 22, 2007 10:42am EDT

Stocks

   

Regulatory News

LONDON, Aug 22 (Reuters) - Britain's healthcare cost-effectiveness watchdog said on Wednesday that Eli Lilly and Co's (LLY.N) drug Alimta would not be recommended as a treatment for lung cancer on the state health service.

The National Institute for Health and Clinical Excellence

(NICE) said its experts had rejected an appeal against the decision by Lilly, because they were not convinced of the clinical and cost effectiveness of Alimta compared with other lung cancer treatments. Alimta is one of a number of new drugs spurned by NICE, to the anger of drugmakers and patient groups.

Last month, however, the watchdog did endorse the medicine for treating certain patients with asbestos-related cancer.

((Reporting by Ben Hirschler; editing by Jane Baird; email: ben.hirschler@reuters.com; Reuters Messaging: ben.hirschler.reuters.com@reuters.net; +44 20 7542 5082)) Keywords: LILLY BRITAIN/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nL22878226
Regulatory News


More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets